Day One Biopharmaceuticals, Inc.
Biotechnology · Healthcare
Board Member, Chairman
2022-01-01–present
Garry Nicholson
Board Member
Day One Biopharmaceuticals, Inc.
Chairman
Day One Biopharmaceuticals, Inc.
Equibles does not estimate personal net worth.
About Garry Nicholson
Garry Nicholson is recorded as Board Member and Chairman at Day One Biopharmaceuticals, Inc. since September 12, 2022. Earlier roles on record: Board Member at TScan Therapeutics, Inc. (TCRX) until October 13, 2026. TScan Therapeutics, Inc. reported in an 8-K filed October 16, 2026 that Garry Nicholson resigned as Board of Directors, effective October 13, 2026. Day One Biopharmaceuticals, Inc. reported in an 8-K filed April 23, 2026 that Garry Nicholson resigned as director, effective April 23, 2026. Day One Biopharmaceuticals, Inc. reported in an 8-K filed September 12, 2022 that Garry Nicholson was appointed chairperson of the Board, effective September 12, 2022. Equibles holds 4 filed executive changes naming Garry Nicholson; each is listed under recent activity with its source filing. Day One Biopharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector.
“On October 13, 2026, each of Garry Nicholson and Gabriela Gruia, M.D., resigned from the Board of Directors (the "Board") of TScan Therapeutics, Inc. (the "Company") and each committee thereof, in each case effective as of October 13, 2026 (the "Resignations").”
“As of the Effective Time, Jeremy Bender, Habib Dable, Scott Garland, William Grossman, Natalie Holles, John Josey, Garry Nicholson and Saira Ramasastry each ceased to be directors of the Company and members of any committee of the Company's board of directors.”
Affiliation history
-
Day One Biopharmaceuticals, Inc.
Board Member
SEC 8-K
Current2022-09-12–present
-
Day One Biopharmaceuticals, Inc.
Chairman
SEC 8-K
Current2022-09-12–present
-
Day One Biopharmaceuticals, Inc.
Board Member
Proxy statement
2022-01-01–2026-04-23
-
Start not stated–2026-10-13